A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer
Oncotarget - United States
doi 10.18632/oncotarget.27536
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 21, 2020
Authors
Publisher
Impact Journals, LLC